Event JSON
{
"id": "d101a96dfa96b69b47b81369e40b59e0caefca1fde2cbb93341eb4e3f4ab1e8e",
"pubkey": "9d3345095e986ded9af724d26a8c5bee050bfd615c32fc5e76981a089c72008e",
"created_at": 1744585596,
"kind": 1,
"tags": [
[
"r",
"https://www.theguardian.com/society/2025/apr/14/melanoma-patients-in-england-get-fast-track-access-to-cancer-vaccine"
],
[
"subject",
"Melanoma patients in England get fast-track access to cancer vaccine"
],
[
"published_at",
"1744585227"
],
[
"image",
"https://i.guim.co.uk/img/media/40335aff708b566272e43ee09d22b8bef85fe0d6/0_160_4832_2901/master/4832.jpg?width=140\u0026quality=85\u0026auto=format\u0026fit=max\u0026s=31eedd78c09edc263a0ca1e0e46c4a41"
],
[
"p",
"9d3345095e986ded9af724d26a8c5bee050bfd615c32fc5e76981a089c72008e",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://i.guim.co.uk/img/media/40335aff708b566272e43ee09d22b8bef85fe0d6/0_160_4832_2901/master/4832.jpg?width=140\u0026quality=85\u0026auto=format\u0026fit=max\u0026s=31eedd78c09edc263a0ca1e0e46c4a41"
],
[
"t",
"liberal:perspective"
],
[
"summary",
"The NHS has launched a trial for a new cancer vaccine, known as iSCIB1+, which helps the immune system recognize cancer cells and respond to immunotherapy treatment. The vaccine is part of the Cancer Vaccine Launch Pad (CVLP) program, which aims to provide 10,000 patients in England with personalized cancer treatments by 2030. The trial is open to patients with advanced skin melanoma and will be conducted at seven hospitals across the country."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqn5e52z27npk7mxhhynfx4rzmaczshltptse0chnknqdq38rjqz8q3cttcd\nhttps://i.guim.co.uk/img/media/40335aff708b566272e43ee09d22b8bef85fe0d6/0_160_4832_2901/master/4832.jpg?width=140\u0026quality=85\u0026auto=format\u0026fit=max\u0026s=31eedd78c09edc263a0ca1e0e46c4a41\nNHS Cancer Vaccine Launch Pad expanded to include trial for patients with advanced type of skin cancerPatients with an advanced type of skin melanoma in England will be given fast-track access to a “revolutionary” new cancer vaccine as part of an NHS trial.The vaccine, known as iSCIB1+ (ImmunoBody), helps the immune system recognise cancer cells and therefore better respond to immunotherapy treatment. Continue reading...\nhttps://www.theguardian.com/society/2025/apr/14/melanoma-patients-in-england-get-fast-track-access-to-cancer-vaccine",
"sig": "5a3039f383ba7dbd9cea1ce87194a79807d6281a589937689c458b82fc6e2f0d7e913799ee04d4216afc3983e8098f5334a925f1a9ea8f9d674c4df0f6639557"
}
